Evidence map›Paper›PMID 30656000›Full record

ArticleClinical case reports2019

Impact of hyperprolactinemia in a patient with polyautoimmunity.

Manuel Rojas, Yhojan Rodríguez, Carolina Ramírez-Santana, Juan-Manuel Anaya

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. A Mechanistic Study ofJournal of microbiology and biotechnology · 2025
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Manuel RojasCenter for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences Universidad del Rosario Bogota Colombia.ORCID https://orcid.org/0000-0002-8604-4658
Yhojan RodríguezCenter for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences Universidad del Rosario Bogota Colombia.ORCID https://orcid.org/0000-0002-0956-1491
Carolina Ramírez-SantanaCenter for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences Universidad del Rosario Bogota Colombia.ORCID https://orcid.org/0000-0003-2137-4899
Juan-Manuel AnayaCenter for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences Universidad del Rosario Bogota Colombia.ORCID https://orcid.org/0000-0002-6444-1249
Universidad del Rosario · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperprolactinemia has been proposed as a triggering factor for autoimmune diseases. The increased levels of prolactin could induce an abnormal immune response. Herein, we present a patient with hyperprolactinemia who developed polyautoimmunity. Patient's symptoms were associated with slightly raised levels of prolactin (20-40 ng/mL) and administration of dopaminergic agonists.

Indexed as

hyperprolactinemiaprolactinSjögren's syndromesystemic lupus erythematosus

Identifiers

PMID30656000
PMCPMC6333117
OpenAlexW2899652208

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.